Increase in HDL-C, Adiponectin Levels With Glucocorticoid Replacement Therapy
Glucocorticoid replacement therapy is associated with an increase in serum levels of adiponectin and high-density lipoprotein cholesterol.
Hormone Replacement Therapy
Testosterone Replacement in Congenital Hypogonadotropic Hypogonadism Has Limited Effects on Bone Health
Testosterone replacement therapy prevents further bone loss at the lumbar and femoral levels in patients with congenital hypogonadotropic hypogonadism, but it does not reliably elevate bone mineral density out of the osteopenic/osteoporotic range.
Hormone Replacement Therapy May Increase Risk for Alzheimer Disease
Long-term use of systemic hormone replacement therapy may slightly increase the risk of developing Alzheimer disease.
Type of Estrogen Therapy Used Has an Impact on Adult Outcomes in Turner Syndrome
An earlier age of onset of puberty may be beneficial for adult bone density in Turner syndrome and type of hormone therapy may have a varying impact on adult health.
Impact of Women’s Health Initiative on Menopausal Hormone Therapy Trends
Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.
Hormone Therapy Linked to Reduced Symptomatic Knee OA in Postmenopausal Women
Hormone therapy in postmenopausal women may be protective against knee OA.
Higher Risk for Venous Thromboembolism With Oral vs Transdermal HRT
Oral preparations of hormone replacement therapy for the treatment of menopausal symptoms are associated with a greater risk for VTE compared with transdermal formulations.
Better Training Needed to Boost LGBTQ Patient Health Care
High-quality health care needs to be provided to lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients, and improved training is necessary to deliver that care.
Clinicians Should Learn to Engage With Transgender Patients
Issues to consider include how to address patients, obtaining inclusive history, and unique clinical challenges.
Cross-Sex Hormone Therapy May Raise Vascular Event Risk in Transgender Persons
The current study sought to compare the incidence of acute cardiovascular events among transgender persons.
Next post in General Endocrinology
